140 related articles for article (PubMed ID: 37573475)
21. Microglia and Brain Macrophages as Drivers of Glioma Progression.
Zheng Y; Graeber MB
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555253
[TBL] [Abstract][Full Text] [Related]
22. Functionalized cell nucleus-penetrating peptide combined with doxorubicin for synergistic treatment of glioma.
Zhang L; Zhang Y; Tai L; Jiang K; Xie C; Li Z; Lin YZ; Wei G; Lu W; Pan W
Acta Biomater; 2016 Sep; 42():90-101. PubMed ID: 27370905
[TBL] [Abstract][Full Text] [Related]
23. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
25. Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.
Sielska M; Przanowski P; Pasierbińska M; Wojnicki K; Poleszak K; Wojtas B; Grzeganek D; Ellert-Miklaszewska A; Ku MC; Kettenmann H; Kaminska B
Br J Cancer; 2020 Aug; 123(3):438-448. PubMed ID: 32390004
[TBL] [Abstract][Full Text] [Related]
26. Molecular interactions between tumor and its microenvironment in malignant gliomas.
Ellert-Miklaszewska A; Pasierbinska M; Poleszak K; Kamińska B
Postepy Biochem; 2018 Oct; 64(2):129-140. PubMed ID: 30656895
[TBL] [Abstract][Full Text] [Related]
27. Origin, activation, and targeted therapy of glioma-associated macrophages.
Xu C; Xiao M; Li X; Xin L; Song J; Zhan Q; Wang C; Zhang Q; Yuan X; Tan Y; Fang C
Front Immunol; 2022; 13():974996. PubMed ID: 36275720
[TBL] [Abstract][Full Text] [Related]
28. Expression of Fas ligand by microglia: possible role in glioma immune evasion.
Badie B; Schartner J; Prabakaran S; Paul J; Vorpahl J
J Neuroimmunol; 2001 Nov; 120(1-2):19-24. PubMed ID: 11694315
[TBL] [Abstract][Full Text] [Related]
29. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
30. Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.
Zhu C; Mustafa D; Zheng PP; van der Weiden M; Sacchetti A; Brandt M; Chrifi I; Tempel D; Leenen PJM; Duncker DJ; Cheng C; Kros JM
Neuro Oncol; 2017 May; 19(5):648-659. PubMed ID: 28453746
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment.
Xu Y; Zhang H; Sun Q; Geng R; Yuan F; Liu B; Chen Q
Front Immunol; 2021; 12():730289. PubMed ID: 34659216
[TBL] [Abstract][Full Text] [Related]
32. Microglia in brain tumors.
Graeber MB; Scheithauer BW; Kreutzberg GW
Glia; 2002 Nov; 40(2):252-259. PubMed ID: 12379912
[TBL] [Abstract][Full Text] [Related]
33. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
Front Immunol; 2018; 9():2750. PubMed ID: 30542347
[TBL] [Abstract][Full Text] [Related]
34. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
35. AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide.
Li J; Sun Y; Sun X; Zhao X; Ma Y; Wang Y; Zhang X
Sci Rep; 2021 Aug; 11(1):17348. PubMed ID: 34462446
[TBL] [Abstract][Full Text] [Related]
36. Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma.
Yang X; Ji C; Qi Y; Huang J; Hu L; Zhou Y; Zou L; Xia Y; Tan F; Yao Y; Chen D
J Neurooncol; 2023 Aug; 164(1):127-139. PubMed ID: 37462801
[TBL] [Abstract][Full Text] [Related]
37. Role of Infiltrating Microglia/Macrophages in Glioma.
Catalano M; D'Alessandro G; Trettel F; Limatola C
Adv Exp Med Biol; 2020; 1202():281-298. PubMed ID: 32034719
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Microglia for the Treatment of Glioma.
Zhou S; Cisse B
World Neurosurg; 2021 Oct; 154():222-227. PubMed ID: 34583499
[TBL] [Abstract][Full Text] [Related]
39. Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy.
Guan X; Hasan MN; Begum G; Kohanbash G; Carney KE; Pigott VM; Persson AI; Castro MG; Jia W; Sun D
Cell Death Dis; 2018 Sep; 9(10):1010. PubMed ID: 30262908
[TBL] [Abstract][Full Text] [Related]
40. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]